Clinical Course Of Disease In Participants With FA-CM

Part of paid clinical trials in La Jolla, California.

Sponsor
Lexeo Therapeutics
Study ID
NCT06865482
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
6 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Characteristics and clinical course of disease In participants with cardiomyopathy associated with Friedreich Ataxia (CLARITY-FA)

Key Dates

First listed
Mar 7, 2025
Start date
Sep 30, 2025
Status verified
Jun 2026
Primary completion
Sep 30, 2027
Completion
Sep 30, 2027

Study Design

Enrollment
65 participants (estimated)

Arms

  • Arm: Cohort 1: Participants ≥16 years of age with FA-CM
    Participants ≥16 years of age with FA-CM
  • Arm: Cohort 2: Participants ≥6 to <16 years of age with FA-CM
    Participants ≥6 to \<16 years of age with FA-CM

Primary Outcome Measure

Characterize cardiac disease presentation and progression among participants [ Time Frame: 26 weeks ]

Central Contacts

Locations (8)

FacilityCityStateZIPSite coordinators
University of California San DiegoLa JollaCalifornia92037
University of South FloridaTampaFlorida33612
[email protected]
Indiana University - Riley Children's HealthIndianapolisIndiana46202
Boston Children's HospitalBostonMassachusetts02115
Mayo ClinicRochesterMinnesota55905
Washington University School of Medicine in St. LouisSt LouisMissouri63110
Cincinnati Children's HospitalCincinnatiOhio45229
[email protected]
Oregon Health & Science UniversityPortlandOregon97239

Find similar trials in La Jolla, CA

By research site
University of California San Diego· La Jolla, CAUniversity of South Florida· Tampa, FLIndiana University - Riley Children's Health· Indianapolis, INBoston Children's Hospital· Boston, MAMayo Clinic· Rochester, MNWashington University School of Medicine in St. Louis· St Louis, MO

Related Studies